Align Technology (ALGN) is a publicly traded Healthcare sector company. As of September 8, 2026, ALGN trades at $153.48 with a market cap of $11.27B and a P/E ratio of 26.80. ALGN moved -3.26% today. Year to date, ALGN is -1.70%; over the trailing twelve months it is +12.15%. Its 52-week range spans $122.00 to $237.23. Analyst consensus is buy with an average price target of $213.44. Rallies surfaces ALGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ALGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $153.48 |
| Market Cap | $11.27B |
| P/E Ratio | 26.80 |
| EPS | $5.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $237.23 |
| 52-Week Low | $122.00 |
| Volume | 583.78K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.14B |
| Net Income | $413.58M |
| Gross Margin | 68.05% |
12 analysts cover ALGN: 0 strong buy, 8 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $213.44.